PlainPharmaWatch

CMS Open Payments · Tool

Medyssey USA, Inc vs Ottobock SE & Co. KGaA

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Ottobock SE & Co. KGaA has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 10,000, versus 2,888 for the other company. Its single largest recorded recipient represents 100.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Medyssey USA, Inc
HHI 2,888 · top recipient 46.2%
Ranked #583 of 1,838 companies by HHI
Ottobock SE & Co. KGaA
HHI 10,000 · top recipient 100.0%
Ranked #130 of 1,838 companies by HHI

Payment Overview

Company A

Medyssey USA, Inc

Total Payments
$307.8K
% of Industry
0.0%
Transactions
38
Avg per Transaction
$8.1K
Recipients
38
Avg per Recipient
$8.1K
Payment Types
1
Top Payment Type
Consulting Fee
Total Payments
$306.0K
% of Industry
0.0%
Transactions
4
Avg per Transaction
$76.5K
Recipients
4
Avg per Recipient
$76.5K
Payment Types
1
Top Payment Type
Grant

Highlighted values indicate the higher figure for each metric.

Total payments compared

Medyssey USA, Inc vs Ottobock SE & Co. KGaA - total reported payments in CMS Open Payments PY2024

Medyssey USA, Inc$307.8KOttobock SE & Co. KGaA$306.0K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Medyssey USA, Inc

Consulting Fee $307.8K

100.0%

Ottobock SE & Co. KGaA

Grant $306.0K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Medyssey USA, Inc

  1. 1

    Anthony Hunkyun Sin

    $142,200.00 · 10 txns

  2. 2

    Daniel K Fahim

    $72,000.00 · 11 txns

  3. 3

    Mark K Chang

    $32,000.00 · 4 txns

  4. 4

    ALAN MCGEE Jr.

    $23,625.00 · 3 txns

  5. 5

    JANGWON YOON

    $14,000.00 · 3 txns

Ottobock SE & Co. KGaA

  1. 1

    Shirley Ryan Abilitylab

    $306,000.00 · 4 txns

Summary Comparison

Metric Medyssey USA, Inc Ottobock SE & Co. KGaA
Total Payments $307.8K $306.0K
% of Industry Total 0.0% 0.0%
Transaction Count 38 4
Avg per Transaction $8.1K $76.5K
Recipient Count 38 4
Avg per Recipient $8.1K $76.5K
Payment Type Count 1 1
Top Payment Type Consulting Fee Grant

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.